Shicheng Yu
Sir Run Run Shaw Hospital
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Application of 5G robotic telesurgery in urology: a multicenter study in the real world.
Journal: Surgical endoscopy
Published: April 13, 2025
The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study.
Journal: Cancer immunology, immunotherapy : CII
Published: March 27, 2025
Effects of Bony Pelvic and Prostate Dimensions on Surgical Difficulty of Robot-Assisted Radical Prostatectomy: An Original Study and Meta-analysis.
Journal: Annals of surgical oncology
Published: April 16, 2024
Identification and validation of SERPINE1 as a prognostic and immunological biomarker in pan-cancer and in ccRCC.
Journal: Frontiers in pharmacology
Published: April 28, 2023
Immunotherapy with or without targeted therapy for metastatic upper tract urothelial carcinoma: case report and literature review.
Journal: Heliyon
Published: September 15, 2022
Effects of treatments on gender differences in patients with localized muscle-invasive bladder cancer.
Journal: International urology and nephrology
Published: February 05, 2022
Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway.
Journal: International journal of biological sciences
Published: November 25, 2021
METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination.
Journal: Molecular therapy. Nucleic acids
Published: June 22, 2021
Camrelizumab monotherapy leading to partial remission for relapsed upper tract urothelial carcinoma after radical nephroureterectomy: a case report.
Journal: Translational andrology and urology
Published: May 10, 2021
Testicular Nuclear Receptor 4 Regulates Proliferation and Apoptosis of Bladder Cancer via Bcl-2.
Journal: Frontiers in molecular biosciences
Published: February 21, 2021
A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify MYO16-AS1 as an Oncogenic lncRNA in Bladder Cancer.
Journal: DNA and cell biology
Published: December 03, 2020
Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer.
Journal: Frontiers in molecular biosciences
Published: October 13, 2020
Last Updated: 09/26/2026